Mach7 Technologies Limited (ASX:M7T)
Australia · Delayed Price · Currency is AUD | Market Cap | 65.80M -9.7% |
| Revenue (ttm) | 29.70M -11.4% |
| Net Income | -10.08M |
| EPS | -0.04 |
| Shares Out | 235.01M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 39,651 |
| Open | 0.2950 |
| Previous Close | 0.2950 |
| Day's Range | 0.2750 - 0.2950 |
| 52-Week Range | 0.2450 - 0.6850 |
| Beta | 0.97 |
| Analysts | Buy |
| Price Target | 0.40 (+42.86%) |
| Earnings Date | Jul 29, 2026 |
About Mach7 Technologies
Mach7 Technologies Limited develops and commercializes medical imaging and data management software solutions for healthcare organizations in North America, the Asia Pacific, the Middle East, Europe, and internationally. It offers eUnity enterprise diagnostic viewer, a zero-footprint viewer that allows medical professionals to remotely access patients’ medical images; vendor-neutral archive (VNA), a vendor-agnostic data management solution, which includes administration tools that allow for the storage, access, retrieval, and viewing of images ... [Read more]
Financial Performance
In fiscal year 2025, Mach7 Technologies's revenue was 33.79 million, an increase of 16.00% compared to the previous year's 29.13 million. Losses were -6.20 million, -22.19% less than in 2024.
Financial StatementsAnalyst Summary
According to 2 analysts, the average rating for M7T stock is "Buy." The 12-month stock price target is $0.40, which is an increase of 42.86% from the latest price.
News
Full Year 2026 Mach7 Technologies Ltd Earnings Presentation Transcript
Full Year 2026 Mach7 Technologies Ltd Earnings Presentation Transcript
Mach7 Technologies Earnings Call Transcript: H2 2026
FY 2026 was a reset year, with a shift to recurring revenue, improved customer experience, and a leaner cost base. Despite revenue declines from contract losses and currency headwinds, the business stabilized in the second half and is positioned for growth in FY 2027, focusing on ARR, new modules, and partnerships.
Mach7 Technologies Annual report: H2 2026
Mach7 Technologies has published its H2 2026 annual report on August 27, 2026.
Mach7 Technologies Earnings release: H2 2026
Mach7 Technologies released its H2 2026 earnings on August 27, 2026, summarizing the period's financial results.
Mach7 Technologies Slides: H2 2026
Mach7 Technologies has posted slides in relation to its H2 2026 quarterly earnings report, which was published on August 27, 2026.
Mach7 Technologies Earnings Call Transcript: Q4 2026
Q4 delivered a third consecutive quarter of positive operating cash flow and a 4% increase in cash to AUD 19.9 million, with ARR up 7.6% year-over-year. The company reaffirmed FY26 guidance, citing a strategic reset, improved cost discipline, and a shift to recurring revenue.
Mach7 Technologies Earnings release: Q4 2026
Mach7 Technologies released its Q4 2026 earnings on July 28, 2026, summarizing the period's financial results.
Mach7 Technologies Transcript: Status update
A comprehensive operational reset has led to positive cash flow, reduced costs, and a shift to recurring revenue. The company is leveraging industry trends in AI and interoperability, expanding its modular product suite, and focusing on disciplined execution and customer-centric innovation to drive growth in FY27.
Mach7 Technologies Slides: Status update
Mach7 Technologies has posted slides in relation to its latest quarterly earnings report, which was published on July 7, 2026.
Mach7 Technologies to Showcase Enterprise Imaging Innovation and New eUnity Digital Pathology Capabilities at SIIM26
Company to highlight enterprise imaging workflows, enterprise viewing, and digital pathology capabilities at Booth 608 BURLINGTON, Vt., June 1, 2026 /PRNewswire/ -- Mach7 Technologies (ASX:M7T), a pro...
Mach7 Technologies CFO Steps Down; VP Shawni Hadfield Takes Interim Role
(RTTNews) - Healthcare Software firm Mach7 Technologies Limited (M7T.AX) announced Monday that Daniel Lee has resigned as Chief Financial Officer to focus on family priorities.
Mach7 Technologies Earnings Call Transcript: Q3 2026
Q3 saw improved financial discipline, with ARR up 2% and positive cash flow. FY26 revenue is expected to dip 15% due to delayed capital deals, but recurring revenue and pipeline growth remain strong. Strategic reset, cost control, and AI-driven innovation are driving future growth.
Mach7 Technologies Slides: Q3 2026
Mach7 Technologies has posted slides in relation to its Q3 2026 quarterly earnings report, which was published on April 23, 2026.
Mach7 Technologies Earnings release: Q3 2026
Mach7 Technologies released its Q3 2026 earnings on April 23, 2026, summarizing the period's financial results.
Mach7 Technologies Earnings Call Transcript: H1 2026
Completed a comprehensive reset, resulting in lower revenue but strong recurring income and gross margins. Strategic investments in modular Flamingo solutions and operational discipline position the company for growth in FY27, with a robust balance sheet and expanding market opportunities.
Mach7 Technologies Quarterly report: H1 2026
Mach7 Technologies has published its H1 2026 quarterly earnings report on February 26, 2026.
Mach7 Technologies Slides: H1 2026
Mach7 Technologies has posted slides in relation to its H1 2026 quarterly earnings report, which was published on February 26, 2026.
Mach7 Technologies Earnings release: H1 2026
Mach7 Technologies released its H1 2026 earnings on February 26, 2026, summarizing the period's financial results.
Q2 2026 Mach7 Technologies Ltd Activities Report Presentation Transcript
Q2 2026 Mach7 Technologies Ltd Activities Report Presentation Transcript
Mach7 Technologies Earnings Call Transcript: Q2 2026
Q2 FY26 saw stable ARR, improved cash flow, and disciplined cost management, with new product launches and strategic focus on Asia and the Middle East. Flamingo is expected to drive growth in H2 FY26 and FY27, though full impact will take time to materialize.
Mach7 Technologies Earnings release: Q2 2026
Mach7 Technologies released its Q2 2026 earnings on January 29, 2026, summarizing the period's financial results.
Mach7 Technologies Transcript: AGM 2025
The meeting reviewed strong FY 2025 financials, a successful CEO transition, and a major strategic reset focused on AI-driven imaging, operational efficiency, and global expansion. All resolutions were presented with no questions raised, and the company is positioned for growth in FY 2027 and beyond.
Mach7 Technologies Slides: FY 2025
Mach7 Technologies has posted slides in relation to its FY 2025 quarterly earnings report, which was published on November 27, 2025.
Mach7 Technologies Launches New Flight Path for Medical Imaging - "from Archive to Architecture" at RSNA 2025
Mach7 soars at RSNA 2025 with an entirely new image built for speed, balance, and freedom. SOUTH BURLINGTON, Vt.
Mach7 Technologies Slides: Investor Presentation
Mach7 Technologies has posted slides in relation to its latest quarterly earnings report, which was published on November 17, 2025.